Normalization of Drug and Therapeutic Concepts with TheraPy

Author:

Cannon MatthewORCID,Stevenson James,Kuzma Kori,Kiwala Susanna,Warner Jeremy L,Griffith Obi LORCID,Griffith Malachi,Wagner Alex HORCID

Abstract

AbstractWorking with therapeutic terminology in the field of medicine can be challenging due to both the number of ways terms can be addressed and the ambiguity associated with different naming strategies. A therapeutic concept can be identified across many facets from ontologies and vocabularies of varying focus, including natural product names, chemical structures, development codes, generic names, brand names, product formulations, or treatment regimens. This diversity of nomenclature makes therapeutic terminology difficult to manage and harmonize. As the number and complexity of available therapeutic ontologies continues to increase, the need for harmonized cross-resource mappings is becoming increasingly apparent. Harmonized concept mappings will enable the linking together of like-concepts despite source-dependent differences in data structure or semantic representation. To support these mappings, we introduce TheraPy, a Python package and web API that constructs stable, searchable merged concepts for drugs and therapeutic terminologies using publicly available resources and thesauri. By using a directed graph approach, TheraPy can capture commonly used aliases, trade names, annotations, and associations for any given therapeutic and combine them under a single merged concept record. Using this approach, we found that TheraPy tends to normalize therapeutic concepts to their underlying active ingredients (excluding non-drug therapeutics, e.g. radiation therapy, biologics), and unifies all available descriptors regardless of ontological origin. In this report, we highlight the creation of 16,069 unique merged therapeutic concepts from 9 distinct sources using TheraPy. Further, we analyze rates of normalization for therapeutic terms taken from publicly available vocabularies.

Publisher

Cold Spring Harbor Laboratory

Reference32 articles.

1. Analysis of variations in the display of drug names in computerized prescriber-order-entry systems

2. Iqbal N , Iqbal N . Imatinib: A breakthrough of targeted therapy in cancer. Chemotherapy Research and Practice, 2014, 1--9. Published online 2014.

3. Imatinib Mesylate (STI-571 Glivec®, Gleevec) Is an Active Agent for Gastrointestinal Stromal Tumours, But Does Not Yield Responses in Other Soft-Tissue Sarcomas That Are Unselected for a Molecular Target: Results from an EORTC Soft Tissue and Bone Sarcoma Group Phase II Study. Excerpta Medica; 2003.

4. Comparing the variability of ingredient, strength, and dose form information from electronic prescriptions with RxNorm drug product descriptions;J Am Med Inform Assoc,2022

5. How Do Drugs Get Named?;AMA J Ethics,2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3